Skip to content
Riskpilot
← Back to search
Sign in
Get full access
fcwBioConsult ApS
APS
Active
Advertising protection
CVR 44151782
Vinkelvej 16, 3520
Farum
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
— employees
www.fcwBioConsult.dk
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
fcwBioConsult ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
0M
2023
0M
0%
2024
1M
+100%
2025
EBITDA
DKK millions
1M
1M
1M
0M
0M
0M
2023
0M
0%
2024
1M
+100%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
299
199
530
Staff expenses
-0
-0
-0
EBITDA
299
199
530
Depreciation & amort.
-0
-0
-0
EBIT
299
199
530
Net financials
0
-2
-9
Profit before tax
299
197
521
Tax
69
44
117
Net profit
231
153
404
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
404
482
812
Equity
271
423
578
Long-term debt
0
0
0
Short-term debt
133
58
235
Total debt
133
58
235
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2023
2025
Equity ratio
71.1%
This company
38.2%
Market median
86% above market
2023
2025
Return on equity
70.0%
This company
18.4%
Market median
280% above market
2023
2025
Net profit margin (of gross profit)
76.3%
This company
2023
2025
Asset turnover (of gross profit)
0.65×
This company
2023
2025
Debt / equity
0.41×
This company
0.62×
Market median
34% below market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-06-20 – 2023-12-31
View
PDF
More on fcwBioConsult ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
